Teladoc Stock Crashes 30% Amid Revenue Woes

Teladoc Health's stock took a nosedive, plummeting nearly 30% in a single day after they reported a disappointing Q2 revenue of $606.9 million, which was less than expected. The company also slashed its full-year revenue guidance and revealed a significant projected decline in its BetterHelp division, prompting an investigation into potentially misleading statements about their financials. What does it mean for you? If you're a Teladoc investor who lost money, you might want to join the investigation. You could potentially recover some of your losses, and with no upfront costs, it’s worth checking out.